# Eli Lilly and Company (LLY) — Q4-2019 Earnings Results

**Report date:** 2020-01-30 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q4-2019

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Up 1.97%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.73 | N/A | +11.87% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based solely on numerical results.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

Eli Lilly's earnings report shows a strong performance in EPS, exceeding expectations by nearly 12%. The stock reacted positively, rising by almost 2%. However, without revenue figures or management commentary, investors may have limited insight into the company's overall performance and future outlook.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q4-2019_